rd capitalized value
Mechanism
Standard book-to-market based value factors mis-classify R&D-heavy firms as "growth" because R&D is expensed (not capitalized) under GAAP. Peters-Taylor 2017 + Eisfeldt-Kim-Papanikolaou 2020 show that adding capitalized R&D back to book equity restores the value premium for tech/biotech and reverses the apparent "value-is-dead" finding of the
Data dependencies
daily_pricesAdjusted-close OHLCV for every US-listed ticker; primary price feed.
fundamentalsQuarterly fundamentals (income, balance, cash-flow) from FMP + SEC.
Expected edge
See referenced paper for original effect size; modern out-of-sample replication may be weaker.
Illustrative pattern only
NOT a backtestIllustrative pattern only — see /app for live backtests and the actual current equity curve.
Explore rd capitalized value on alphactor.ai
See which tickers this family is currently firing on, with live signals and rankings.